Insights
Attorney Authored
Deal Lawyers: Biotech Spin-Off Transactions
October 17, 2025
By Andrew Goodman,Daniel Nicholas,Seo Salimiand Ziemowit T. Smulkowski
Partners Andrew Goodman, Daniel Nicholas, Seo Salimi and Ziemowit Smulkowski discuss business reasons for biotech spin-offs, as well as spin-off considerations and planning, in this article published by Deal Lawyers.
Contributors
Practice Areas
For More Information